Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy

Hahné, Susan; Ramsay, Mary; Balogun, Koye; Wj, Edmunds; Mortimer, P.

doi:10.1016/j.jcv.2003.09.016

Cited by 150 publications

(126 citation statements)

References 17 publications

Supporting

Mentioning

118

Contrasting

Unclassified

Order By: Relevance

“…Incidence of acute hepatitis B in the UK remains low (164), but MSM represent a risk group and routine testing and vaccination is recommended for those at elevated risk, comprising all MSM, male and female sex workers, and people who inject drugs (165).…”

Section: Hepatitis Bmentioning

confidence: 99%

2016 United Kingdom national guideline on the sexual health care of men who have sex with men

et al. 2018

View full text Add to dashboard Cite

This guideline is intended for use in UK Genitourinary medicine clinics and sexual health services but is likely to be of relevance in all sexual health settings, including general practice and Contraception and Sexual Health (CASH) services, where men who have sex with men (MSM) seek sexual health care or where addressing the sexual health needs of MSM may have public health benefits. For the purposes of this document, MSM includes all gay, bisexual and all other males who have sex with other males and both cis and trans men. This document does not provide guidance on the treatment of particular conditions where this is covered in other British Association for Sexual Health and HIV (BASHH) Guidelines but outlines best practice in multiple aspects of the sexual health care of MSM. Where prevention of sexually transmitted infections including HIV can be addressed as an integral part of clinical care, this is consistent with the concept of combination prevention and is included. The document is designed primarily to provide guidance on the direct clinical care of MSM but also makes reference to the design and delivery of services with the aim of supporting clinicians and commissioners in providing effective services. Methodology This document was produced in accordance with the guidance set out in the BASHH CEG’s document ‘Framework for guideline development and assessment’ published in 2010 at http://www.bashh.org/guidelines and with reference to the Agree II instrument. Following the production of the updated framework in April 2015, the GRADE system for assessing evidence was adopted and the draft recommendations were regraded. Search strategy (see also Appendix 1) Ovid Medline 1946 to December 2014, Medline daily update, Embase 1974 to December 2014, Pubmed NeLH Guidelines Database, Cochrane library from 2000 to December 2014. Search language English only. The search for Section 3 was conducted on PubMed to December 2014. Priority was given to peer-reviewed papers published in scientific journals, although for many issues evidence includes conference abstracts listed on the Embase database. In addition, for ‘Identification of problematic recreational drug and alcohol use’ section and ‘Sexual problems and dysfunctions in MSM’ section, searches included PsycINFO. Methods Article titles and abstracts were reviewed and if relevant the full text article was obtained. Priority was given to randomised controlled trial and systematic review evidence, and recommendations made and graded on the basis of best available evidence. Piloting and feedback The first draft of the guideline was circulated to the writing group and to a small group of relevant experts, third sector partners and patient representatives who were invited to comment on the whole document and specifically on particular sections. The revised draft was reviewed by the CEG and then reviewed by the BASHH patient/public panel and posted on the BASHH website for public consultation. The final draft was piloted before publication. Guideline update The guidelines will be reviewed and revised in five years’ time, 2022.

show abstract

Section: Hepatitis Bmentioning

confidence: 99%

2016 United Kingdom national guideline on the sexual health care of men who have sex with men

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In Spain and in England, the HBsAg prevalence among sex workers varies between 6-7% [23,24]. In many European countries immigrants from highly endemic regions are 5-90 times more frequently affected by HBV than the general population [25][26][27][28][29]. Other populations at high risk of HBV infection are MSM, and those having multiple sex partners [30,31].…”

Section: T a B L Ementioning

confidence: 99%

Surveillance and epidemiology of hepatitis B and C in Europe – a review

2008

View full text Add to dashboard Cite

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are frequent causes of acute and chronic hepatitis worldwide and leading causes for hepatic cirrhosis and cancer. There is a distinct geographical variation in HBV and HCV incidence and prevalence in the European Union (EU) and European Economic Area/European Free Trade Association (EEA/EFTA) member states and neighbouring countries. The HBV carrier prevalence ranges from 0.1 to 8.0% and that of HCV from 0.1 to 6.0%. Within the last few years, the HBV incidence has decreased while the HCV incidence has increased. Both diseases are concentrated in certain subpopulations, such as injecting drug users, with tens of times higher prevalence than in the general population. Most EU and EEA/EFTA countries have a surveillance system for HBV and HCV infections, but due to differences in system structures, reporting practices, data collection methods and case definitions used, the surveillance data are difficult to compare across countries. The harmonisation and strengthening of HBV and HCV surveillance at the European level is of utmost importance to obtain more robust data on these diseases.

show abstract

“…4 In the UK, a low-prevalence country, the majority of chronic HBV infection occurs among migrant populations who acquired their infection outside of the UK. 5 The number of people with chronic HBV infection living in the UK is unknown -with estimates ranging from 86 000 to 326 000. [6][7][8] UK testing strategies include antenatal screening, 9 and testing blood donors and at-risk populations, including people who inject drugs, prisoners, patients undergoing haemodialysis, and healthcare workers.…”

Section: Introductionmentioning

confidence: 99%

Low hepatitis B testing among migrants: a cross-sectional study in a UK city

et al. 2016

View full text Add to dashboard Cite

BackgroundIn 2012, hepatitis B virus (HBV) testing of people born in a country with a prevalence of ≥2% was recommended in the UK. Implementation of this recommendation requires an understanding of prior HBV testing practice and coverage, for which there are limited data. AimTo estimate the proportion of migrants tested for HBV and explore GP testing practices and barriers to testing. Design and settingA cross-sectional study of (a) migrants for whom testing was recommended under English national guidance, living in Bristol, and registered with a GP in 2006-2013, and (b) GPs practising in Bristol.

show abstract

Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy

Cited by 150 publications

References 17 publications

2016 United Kingdom national guideline on the sexual health care of men who have sex with men

2016 United Kingdom national guideline on the sexual health care of men who have sex with men

Surveillance and epidemiology of hepatitis B and C in Europe – a review

Low hepatitis B testing among migrants: a cross-sectional study in a UK city

Contact Info

Product

Resources

About